Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Larson

Showing results (801-810 of 997) with videos related to

Pageof 100
Sort By:
Circulation|December 21, 2017
Genetic Architecture of the Cardiovascular Risk ProteomeMark D Benson, Qiong Yang, Debby Ngo, et al.
BMJ (Clinical Research Ed.)|April 28, 2018
Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart StudyLaila Staerk, Biqi Wang, Sarah R Preis, et al.
Neurology|March 29, 2007
Inflammatory biomarkers are associated with total brain volume: the Framingham Heart StudyA L Jefferson, J M Massaro, P A Wolf, et al.
Hypertension (Dallas, Tex. : 1979)|February 29, 2012
Circulating vascular growth factors and central hemodynamic load in the communityJustin P Zachariah, Vanessa Xanthakis, Martin G Larson, et al.
Plos One|May 9, 2014
Whole blood gene expression and atrial fibrillation: the Framingham Heart StudyHonghuang Lin, Xiaoyan Yin, Kathryn L Lunetta, et al.
Clinical Chemistry|October 16, 2012
Distribution and clinical correlates of the interleukin receptor family member soluble ST2 in the Framingham Heart StudyErin E Coglianese, Martin G Larson, Ramachandran S Vasan, et al.
Hypertension (Dallas, Tex. : 1979)|July 27, 2016
Relations of Arterial Stiffness and Brachial Flow-Mediated Dilation With New-Onset Atrial Fibrillation: The Framingham Heart StudyAmir Y Shaikh, Na Wang, Xiaoyan Yin, et al.
ESMO Open|August 9, 2021
Quality of life with first-line pembrolizumab for PD-L1-positive advanced gastric/gastroesophageal junction adenocarcinoma: results from the randomised phase III KEYNOTE-062 studyE Van Cutsem, A Valderrama, Y-J Bang, et al.
Circulation|August 24, 2005
CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart StudyDavid H McDermott, Qiong Yang, Sekar Kathiresan, et al.
JAMA Neurology|June 6, 2022
Association of Aortic Stiffness and Pressure Pulsatility With Global Amyloid-β and Regional Tau Burden Among Framingham Heart Study Participants Without DementiaLeroy L Cooper, Adrienne O'Donnell, Alexa S Beiser, et al.
Pageof 100

Showing results (801-810 of 997) with videos related to

Sort By:
Pageof 100
Circulation|December 21, 2017
Genetic Architecture of the Cardiovascular Risk ProteomeMark D Benson, Qiong Yang, Debby Ngo, et al.
BMJ (Clinical Research Ed.)|April 28, 2018
Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart StudyLaila Staerk, Biqi Wang, Sarah R Preis, et al.
Neurology|March 29, 2007
Inflammatory biomarkers are associated with total brain volume: the Framingham Heart StudyA L Jefferson, J M Massaro, P A Wolf, et al.
Hypertension (Dallas, Tex. : 1979)|February 29, 2012
Circulating vascular growth factors and central hemodynamic load in the communityJustin P Zachariah, Vanessa Xanthakis, Martin G Larson, et al.
Plos One|May 9, 2014
Whole blood gene expression and atrial fibrillation: the Framingham Heart StudyHonghuang Lin, Xiaoyan Yin, Kathryn L Lunetta, et al.
Clinical Chemistry|October 16, 2012
Distribution and clinical correlates of the interleukin receptor family member soluble ST2 in the Framingham Heart StudyErin E Coglianese, Martin G Larson, Ramachandran S Vasan, et al.
Hypertension (Dallas, Tex. : 1979)|July 27, 2016
Relations of Arterial Stiffness and Brachial Flow-Mediated Dilation With New-Onset Atrial Fibrillation: The Framingham Heart StudyAmir Y Shaikh, Na Wang, Xiaoyan Yin, et al.
ESMO Open|August 9, 2021
Quality of life with first-line pembrolizumab for PD-L1-positive advanced gastric/gastroesophageal junction adenocarcinoma: results from the randomised phase III KEYNOTE-062 studyE Van Cutsem, A Valderrama, Y-J Bang, et al.
Circulation|August 24, 2005
CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart StudyDavid H McDermott, Qiong Yang, Sekar Kathiresan, et al.
JAMA Neurology|June 6, 2022
Association of Aortic Stiffness and Pressure Pulsatility With Global Amyloid-β and Regional Tau Burden Among Framingham Heart Study Participants Without DementiaLeroy L Cooper, Adrienne O'Donnell, Alexa S Beiser, et al.
Pageof 100